STOCK TITAN

BDX (BDX) holder files notice to sell 629 shares under SEC Rule 144

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder of BDX has filed a notice under Rule 144 to sell 629 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an approximate sale date of 12/17/2025. The planned sale has an aggregate market value of $123,529.31, compared with 285,418,551 shares of the same class reported as outstanding.

The shares to be sold were acquired on 11/26/2025 as Restricted Stock Units from the issuer, in an amount of 629 units, with the same date listed as the date of payment and the nature of payment noted as "N/A." By signing the notice, the seller represents that they do not know of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filing for BDX disclose?

The notice states that a BDX shareholder intends to sell 629 shares of common stock under Rule 144 on the NYSE, with an aggregate market value of $123,529.31.

How many BDX shares are planned to be sold and on which exchange?

The shareholder plans to sell 629 common shares of BDX on the NYSE, using Morgan Stanley Smith Barney LLC Executive Financial Services as the broker.

When and how were the BDX shares being sold under Rule 144 acquired?

The shares were acquired on 11/26/2025 as Restricted Stock Units from the issuer, in the amount of 629, with the date of payment also listed as 11/26/2025 and the nature of payment shown as "N/A."

How many BDX shares of this class are reported as outstanding in the Form 144?

The notice reports 285,418,551 shares of the relevant class of BDX common stock as outstanding.

What representation does the seller make about undisclosed information in the BDX Form 144?

By signing, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

Is the BDX Form 144 sale connected to a Rule 10b5-1 trading plan?

The form includes a field for the Date of Plan Adoption or Giving of Instruction if relying on Rule 10b5-1, but no specific date is shown in the provided content.

Becton Dickinson & Co

NYSE:BDX

BDX Rankings

BDX Latest News

BDX Latest SEC Filings

BDX Stock Data

56.05B
283.68M
0.57%
92.26%
1.59%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
FRANKLIN LAKES